Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02601833 · ClinicalTrials.gov registry record · Phase 3

Effectiveness of Silver Diamine Fluoride as a Treatment for Caries in Comparison to Traditional Restorative Techniques

A Phase 3 study of Caries, sponsored by University of Michigan.

Completed
Registry status
Phase 3
Development phase
98
Enrollment target
2
Study locations

NCT02601833 is a Phase 3 study of Caries that has completed, run by University of Michigan. The registered enrollment target is 98 participants, above the 46-participant average among 7 other Caries trials with a reported enrollment target (113% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02601833, a Phase 3 study of Caries, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 3
Development phase
98 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare standard fillings and silver diamine fluoride (SDF) for treatment of cavities in baby teeth. The investigators will compare the effectiveness of stopping the cavity, cost of the treatments and the opinions of the families and the dental providers.

Conditions Studied

Interventions

  • DEVICE Silver Diamine Fluoride
  • PROCEDURE Conventional Caries Management

Study Locations (2)

Michigan

  • University of Michigan School of Dentistry - Ann Arbor
  • Mott Children's Health Center - Flint

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2016-01
Est. Completion 2020-09-18
Phase Phase 3

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02601833

The ClinicalTrials.gov registry entry for NCT02601833 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 46-participant average among 7 other Caries trials with a reported enrollment target (113% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Caries appearing as the primary indexed condition, and to 2 interventions - of which Silver Diamine Fluoride is the first listed.

NCT02601833 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02601833 about?

NCT02601833 is a clinical study titled "Effectiveness of Silver Diamine Fluoride as a Treatment for Caries in Comparison to Traditional Restorative Techniques". The purpose of this study is to compare standard fillings and silver diamine fluoride (SDF) for treatment of cavities in baby teeth. The investigators will compare the effectiveness of stopping the cavity, cost of the treatments and the opinions of the families and the dental providers.

What is the current status of trial NCT02601833?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2016-01. Estimated completion is 2020-09-18.

What conditions does trial NCT02601833 study?

This clinical trial studies the following conditions: Caries.

What interventions are being tested in trial NCT02601833?

The interventions under investigation include: Silver Diamine Fluoride (DEVICE), Conventional Caries Management (PROCEDURE).

Who is sponsoring clinical trial NCT02601833?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02601833 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.